People's United Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $802K | Buy |
8,555
+644
| +8% | +$60.4K | 0.02% | 362 |
|
|
2021
Q4 | $674K | Sell |
7,911
-99
| -1% | -$8.44K | 0.02% | 432 |
|
|
2021
Q3 | $768K | Sell |
8,010
-191
| -2% | -$18.3K | 0.02% | 433 |
|
|
2021
Q2 | $798K | Buy |
8,201
+254
| +3% | +$24.7K | 0.02% | 428 |
|
|
2021
Q1 | $773K | Buy |
7,947
+87
| +1% | +$8.46K | 0.02% | 407 |
|
|
2020
Q4 | $753K | Buy |
7,860
+84
| +1% | +$8.05K | 0.02% | 384 |
|
|
2020
Q3 | $748K | Sell |
7,776
-11
| -0.1% | -$1.06K | 0.02% | 348 |
|
|
2020
Q2 | $950K | Buy |
7,787
+1,630
| +26% | +$199K | 0.03% | 297 |
|
|
2020
Q1 | $533K | Buy |
6,157
+275
| +5% | +$23.8K | 0.02% | 362 |
|
|
2019
Q4 | $632K | Buy |
5,882
+103
| +2% | +$11.1K | 0.02% | 447 |
|
|
2019
Q3 | $521K | Sell |
5,779
-189
| -3% | -$17K | 0.01% | 514 |
|
|
2019
Q2 | $504K | Sell |
5,968
-4,523
| -43% | -$382K | 0.01% | 545 |
|
|
2019
Q1 | $924K | Buy |
+10,491
| New | +$924K | 0.03% | 406 |
|